| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0097 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0058 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |